ArticleJournal of the Chinese Medical Association : JCMA2026
Tumor-suppressive circRNAs in colorectal cancer spheroids and patients.
Article in Journal of the Chinese Medical Association : JCMA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCancer stem cells pose significant clinical challenges in patients with colorectal cancer, as they complicate chemotherapy treatment and reduce survival rates. Investigating cancer stem cells may help elucidate the mechanisms driving therapeutic resistance and disease progression. Recent studies suggest that circular RNAs (circRNAs) play crucial roles in tumor formation and may offer potential for early diagnosis and novel treatment strategies. However, comprehensive validations of these circRNAs remain limited to date. The aim of this study was to elucidate the molecular roles of circRNAs that are downregulated in colorectal cancer stem-like cell populations.
methodsWe established 3D spheroid cultures using HCT-15 and WiDr cell lines as cancer stem cell models. Bulk RNA sequencing profiled circRNA and mRNA expression, followed by bioinformatic analyses using CircInteractome, CircBank, miRDB, and TargetScan to construct circRNA-miRNA-mRNA interaction networks.
resultsCircRNA sequencing revealed predominant downregulation of circRNAs in spheroid cultures. Integration with clinical datasets comprising 788 colorectal cancer patients identified 15 circRNAs consistently downregulated in both spheroid models and metastatic tissues. Among these, hsa_circ_0039776 and hsa_circ_0067353 emerged as key tumor-suppressive candidates, predicted to regulate three oncogenic miRNAs-hsa-miR-614, hsa-miR-645, and hsa-miR-4689-significantly upregulated in advanced-stage patients. Cross-validation confirmed circRNA-miRNA and miRNA-mRNA interactions, and four tumor-suppressive genes ( CCL5 , INSC , SLC9A1 , SLC34A1 ) were associated with improved survival. Gene set enrichment analysis suggested these networks modulate cancer stem cell phenotypes, including inhibition of differentiation, resistance to apoptosis, and enhancement of DNA damage repair.
conclusionThis study identifies hsa_circ_0039776 and hsa_circ_0067353 as novel tumor-suppressive circRNAs reduced in colorectal cancer spheroids and metastatic lesions. The circRNA-miRNA-mRNA regulatory network implicates oncogenic miRNAs and downstream tumor-suppressive targets correlating with favorable survival and cancer stemness. These findings underscore the potential of circRNAs as diagnostic biomarkers and therapeutic targets in colorectal cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.